"Beware ! The cure may be worse than the disease", Christian Vélot

Publié le 07 septembre 2021 - 11:47
Christian Vélot
F. Froger / D6
Christian Vélot
F. Froger / D6

Professor Vélot teaches molecular genetics at Paris-Sud University, and is the Scientific Director of the CRIIGEN (Comité de recherche de l’information indépendante du génie génétique, Research Committee on Independent information on genetic engineering).

[English subtitiles available]

In this interview with Xavier Azalbert, he discusses the nature of the Sars-Cov-2 virus, which he considers dangerous owing to the unknowns surrounding it, and to the great diversity of symptoms it unleashes. Why have the authorites chosen to rely upon such novel vaccine-technologies, technologies for which we lack all hindsight, to fight a virus which itself is attended by so much uncertainty ? This will almost certainly prove to ahve been a strategic error. Professor Vélot is also concerned by the fact that early treatments, such as the hydroxychloroquine protocol administered at Marseilles by France’s leading virologist, Professor Didier Raoult, have been derided in favour of untested or even toxic molecules such as Remdesivir which also happens to be mutageneous. 

Professor Vélot explains in detail the three vaccine-categories currently being marketed in the West : inactivated virus-, recombinant protein- and genetic vaccines. The haste with which the public health agencies have issued Emergency Use Authorisations for the Pfizer-Moderna/J& J and AstraZeneca vaccines is, he says, both unprecedented and extraordinarily imprudent. Stretching over years and sometimes decades, phase 3 vaccine trials normally include, inter alia, studies on immunotoxicity, genotoxicity and interactions with the human genome. Here, those studies, along with many other essential data-sets, are entirely lacking.

The virus, he explains, does not mutate so much as recombine with viruses from other families, a peculiarity which raises vexed matters such as immune escape, vaccine efficacy and the risk/benefit ratio.  

Finally, Professor Vélot finds the « group think » amongst decision-making bodies deplorable to say the least, and the very antithesis of scientific method. En passant, he points to publicly-stated, glaring errors made by Dr. Alain Fischer, the French Government’s « Mr Vaccine ».

Besides his patent skills as a pedagogue and polemicist, Professor Vélot is a master in his field, a clear-thinker who brings us back to the basics of scientific enquiry.


Peter McCullough, encore un debriefing
"There was no cause to grant Pfizer full approval", Prof. Peter McCullough
Professor McCullough has done France Soir the honour of speaking to our audience on several recent occasions, latterly in relation to purportedly scientific utterances...
02 septembre 2021 - 19:28
Stephanie Seneff
"I can't imagine anybody pregnant agreeing to get that vaccine" Stephanie Seneff
Dr. Stephanie Seneff is Senior Research Scientist at the MIT Computer Science and Artificial Intelligence Laboratory. She holds a B.S. in Biophysics, M.S. and E.E. deg...
16 août 2021 - 15:00

L'article vous a plu ? Il a mobilisé notre rédaction qui ne vit que de vos dons.
L'information a un coût, d'autant plus que la concurrence des rédactions subventionnées impose un surcroît de rigueur et de professionnalisme.

Avec votre soutien, France-Soir continuera à proposer ses articles gratuitement  car nous pensons que tout le monde doit avoir accès à une information libre et indépendante pour se forger sa propre opinion.

Vous êtes la condition sine qua non à notre existence, soutenez-nous pour que France-Soir demeure le média français qui fait s’exprimer les plus légitimes.

Si vous le pouvez, soutenez-nous mensuellement, à partir de seulement 1€. Votre impact en faveur d’une presse libre n’en sera que plus fort. Merci.

Je fais un don à France-Soir

Dessin de la semaine

Soutenez l'indépendance de FS

Faites un don

Nous n'avons pas pu confirmer votre inscription.
Votre inscription à la Newsletter hebdomadaire de France-Soir est confirmée.

La newsletter France-Soir

En vous inscrivant, vous autorisez France-Soir à vous contacter par e-mail.